Showing results (631-640 of 723) with videos related to

Sort By:
Pageof 73
Magnetic Resonance Imaging|December 19, 2000
Mapping of the cerebral response to hypoxia measured using graded asymmetric spin echo EPIG C Houston, N G Papadakis, T A Carpenter, et al.
Magnetic Resonance Imaging|October 12, 2001
Mapping of brain activation in response to pharmacological agents using fMRI in the ratG C Houston, N G Papadakis, T A Carpenter, et al.
Molecular Pharmacology|August 28, 2013
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismBrian D Hudson, Bharat Shimpukade, Amanda E Mackenzie, et al.
Therapeutic Innovation & Regulatory Science|January 5, 2021
Effective Data Sharing as a Conduit for Advancing Medical Product DevelopmentStephen R Karpen, J Kael White, Ariana P Mullin, et al.
American Journal of Respiratory and Critical Care Medicine|August 12, 1998
Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndromeD K Madtes, G Rubenfeld, L D Klima, et al.
Chemical Senses|June 16, 2018
Flavor Alterations Associated with Miracle Fruit and Gymnema sylvestreSonia D Hudson, Charles A Sims, Asli Z Odabasi, et al.
Physical Review Letters|April 7, 2010
Wrinkling and strain softening in single-wall carbon nanotube membranesE K Hobbie, D O Simien, J A Fagan, et al.
Clinical and Translational Science|July 24, 2020
Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's DiseaseAriana P Mullin, Diane Corey, Emily C Turner, et al.
The Journal of Biological Chemistry|January 12, 2011
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3Johannes Schmidt, Nicola J Smith, Elisabeth Christiansen, et al.
Carbohydrate Research|June 16, 1992
The conformational behaviour of the cardiac glycoside digoxin as indicated by NMR spectroscopy and molecular dynamics calculationsA E Aulabaugh, R C Crouch, G E Martin, et al.
Pageof 73